Janon, Mia .

HRN: 21-51-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2023
CEFUROXIME 1.5GM (VIAL)
02/11/2023
02/11/2023
IV
1.5GMS
On Call To OR
Stat Cs
Waiting Final Action 
02/11/2023
CEFUROXIME 1.5GM (VIAL)
02/11/2023
02/18/2023
IV
1.5g
Q8
Ltcs
Waiting Final Action 
02/12/2023
CEFUROXIME 500MG (TAB)
02/12/2023
02/18/2023
ORAL
500
BID
LTCS
Waiting Final Action 
02/12/2023
CEFUROXIME 500MG (TAB)
02/12/2023
02/18/2023
ORAL
500
BID
LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: